These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17969455)

  • 41. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Too much of a good thing: Sustained type 1 interferon signaling limits humoral responses to secondary viral infection.
    Teijaro JR
    Eur J Immunol; 2016 Feb; 46(2):300-2. PubMed ID: 26783074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN.
    Montoya M; Edwards MJ; Reid DM; Borrow P
    J Immunol; 2005 Feb; 174(4):1851-61. PubMed ID: 15699111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of humoral immunity explored through studies of LCMV infection.
    Slifka MK
    Curr Top Microbiol Immunol; 2002; 263():67-81. PubMed ID: 11987820
    [No Abstract]   [Full Text] [Related]  

  • 45. Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression.
    Zarozinski CC; McNally JM; Lohman BL; Daniels KA; Welsh RM
    J Virol; 2000 Apr; 74(8):3650-8. PubMed ID: 10729141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
    Le Bon A; Etchart N; Rossmann C; Ashton M; Hou S; Gewert D; Borrow P; Tough DF
    Nat Immunol; 2003 Oct; 4(10):1009-15. PubMed ID: 14502286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus.
    Khanolkar A; Fuller MJ; Zajac AJ
    Immunol Res; 2002; 26(1-3):309-21. PubMed ID: 12403369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation.
    Shaabani N; Khairnar V; Duhan V; Zhou F; Tur RF; Häussinger D; Recher M; Tumanov AV; Hardt C; Pinschewer D; Christen U; Lang PA; Honke N; Lang KS
    J Autoimmun; 2016 Feb; 67():82-89. PubMed ID: 26553386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major.
    Crosby EJ; Clark M; Novais FO; Wherry EJ; Scott P
    J Immunol; 2015 Oct; 195(7):3301-10. PubMed ID: 26290604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.
    Binder D; van den Broek MF; Kägi D; Bluethmann H; Fehr J; Hengartner H; Zinkernagel RM
    J Exp Med; 1998 Jun; 187(11):1903-20. PubMed ID: 9607930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stage of primary infection with lymphocytic choriomeningitis virus determines predisposition or resistance of mice to secondary bacterial infections.
    Gumenscheimer M; Balkow S; Simon MM; Jirillo E; Galanos C; Freudenberg MA
    Med Microbiol Immunol; 2007 Jun; 196(2):79-88. PubMed ID: 17136407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration.
    McKall-Faienza KJ; Kawai K; Kündig TM; Odermatt B; Bachmann MF; Zakarian A; Mak TW; Ohashi PS
    Int Immunol; 1998 Apr; 10(4):405-12. PubMed ID: 9620596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
    Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type I IFN substitutes for T cell help during viral infections.
    Wiesel M; Kratky W; Oxenius A
    J Immunol; 2011 Jan; 186(2):754-63. PubMed ID: 21160039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus.
    Varga SM; Welsh RM
    J Immunol; 1998 Oct; 161(7):3215-8. PubMed ID: 9759834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cell expansion is the limiting factor of virus control in mice with attenuated TCR signaling: implications for human immunodeficiency.
    Hillen KM; Gather R; Enders A; Pircher H; Aichele P; Fisch P; Blumenthal B; Schamel WW; Straub T; Goodnow CC; Ehl S
    J Immunol; 2015 Mar; 194(6):2725-34. PubMed ID: 25672755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses.
    Honke N; Shaabani N; Merches K; Gassa A; Kraft A; Ehrhardt K; Häussinger D; Löhning M; Dittmer U; Hengel H; Recher M; Lang PA; Lang KS
    Eur J Immunol; 2016 Feb; 46(2):372-80. PubMed ID: 26507703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hematopoietic and nonhematopoietic cells promote Type I interferon- and TLR7-dependent monocytosis during low-dose LCMV infection.
    Buechler MB; Gessay GM; Srivastava S; Campbell DJ; Hamerman JA
    Eur J Immunol; 2015 Nov; 45(11):3064-72. PubMed ID: 26289159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction.
    Welsh RM
    J Exp Med; 1978 Jul; 148(1):163-81. PubMed ID: 307587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral immunosuppression: disabling the guards.
    Colonna M
    J Clin Invest; 2004 Mar; 113(5):660-2. PubMed ID: 14991061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.